Safety and Efficacy Study for the Treatment of Painful Diabetic Neuropathy

NCT01475786 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

104

Enrollment

INDUSTRY

Sponsor class

Conditions

Painful Diabetic Neuropathies

Interventions

BIOLOGICAL: Low Dose: 16 mg Engensis (VM202)
BIOLOGICAL: High Dose: 32 mg Engensis (VM202)
OTHER: Control- Placebo (normal saline)

Sponsor

Helixmith Co., Ltd.